Research has found that GLP-1 receptors, found in medications like Wegovy and Monjaro, may offer health benefits beyond the ...

Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

In a nutshell Fat hidden between muscle fibers may predict heart problems better than traditional measures like BMI or weight, especially in women. This type of fat can be detected through specialized ...